Characteristics of thymus hormones
Thymus hormones play an important role in the context of endocrine regulation and immune response. Their effects are diverse and affect both cellular and humoral immunity.
Thymosins In vitro, these substances act as powerful stimulators of immune processes. They ensure the differentiation of T lymphocytes as well as the expression of specific receptors on their surface. In addition, thymosins activate lymphokine production and stimulate immunoglobulin production.
Thymopoietins This group of hormones is localized in the nuclei of the epithelial framework of the thymus, as well as in the basal keratinocytes of the epidermis. Key functions of thymopoietins:
- Initiation of prothymocyte maturation into fully functional T cells (while the immunological spectrum of the cells remains unchanged).
- Direct interaction with cholinergic receptors.
- Alteration of the secretory activity of corticotrophs located in the pituitary gland.
In clinical practice, thymopentin is actively used — a drug representing a fragment of thymopoietin (including amino acid residues 32–36). It is indispensable in the treatment of primary immunodeficiency states, in particular DiGeorge syndrome.
Parathymosin This is a polypeptide analogue of prothymosin. In terms of its physiological action, it largely duplicates the effects characteristic of thymosin.
Etiotropic principle of therapy
Etiotropic treatment is always aimed at the root cause of the disease. The main task of the physician in this case is to completely eliminate, stop, or at least reduce the intensity and duration of the impact of pathogenic factors on the tissues of the endocrine glands.
Physical factors are among those that require mandatory and primary elimination. High-dose radiation and direct mechanical trauma to the glandular tissue are identified as the most significant threats. Without halting these triggers, further restoration of organ function is impossible.
Pathogenetic therapy
If etiotropic therapy targets the cause, pathogenetic therapy targets the mechanisms of disease development. Its main goal is to block pathological processes at the molecular, cellular, and tissue levels.
Therapy should support the optimal progression of the following processes:
- Direct synthesis of hormones within the gland cells.
- Transportation of hormone molecules in the bloodstream and interstitial fluid.
- Binding and interaction of hormones with specific cellular receptors.
- Adequate intracellular metabolism.
Two main methods are used to implement this principle:
- Administration of hormone preparations. This approach is used as replacement therapy when the body experiences a deficiency of its own hormones or an insufficiency of their physiological effects.
- Administration of hormone blockers and their effects. This tactic is justified in cases of pathological glandular hyperactivity or excessive hormone production, when it is necessary to artificially reduce their influence on target organs.
Symptomatic therapy
Even with the successful elimination of the cause and the blocking of disease mechanisms, the patient may suffer from severe clinical manifestations. The goal of symptomatic therapy is to prevent or eliminate unpleasant, distressing symptoms that significantly worsen the patient's general condition.
The following groups of medications are used for symptomatic correction:
- Anti-stress drugs that help the nervous system cope with stress.
- Blood pressure correction agents (antihypertensives for hypertension or hypertensives for blood pressure drops).
- Tranquilizers to reduce anxiety and emotional tension.
- Various substances that promote the normalization of metabolic processes and restore lost functions of organs and entire physiological systems.
Briefly: answers to topical questions
What surgical methods are used in the etiotropic therapy of endocrinopathies?
Surgical removal of a tumor when the cause of adrenal insufficiency is established is cited in sources as a surgical method of etiotropic therapy for endocrinopathies.
There are no surgical cures for type 1 diabetes mellitus; isolated pancreas transplantation is not recommended for treating the disease. No surgical treatments have been developed for hypothyroidism.
What drugs are used as hormone receptor blockers?
Hormone receptor blockers mentioned in sources include:
- Tamoxifen — blocks estrogen receptors.
- Flutamide — blocks androgen receptors.
- Conivaptan — a non-selective vasopressin receptor blocker: $V_{1A}$ and $V_2$.
- Tolvaptan — a selective vasopressin $V_2$-receptor blocker.
For conivaptan and tolvaptan, sources also indicate that at the time of writing, they were undergoing Phase III clinical trials; drugs of this group are not registered or used in the Russian Federation.
What are the pathogenetic mechanisms of DiGeorge syndrome?
The pathogenesis of DiGeorge syndrome is based on a disruption of embryonic development (fetal injury at the 8th week of gestation), leading to aplasia or hypoplasia of the thymus and absence of the parathyroid glands.
Mechanisms include:
- Defect in the epithelial microenvironment factors of the thymus.
- Absence of cellular immune response due to thymic dysgenesis.
- Absence of a restrictive inflammatory response to pyogenic microorganisms (which can lead to generalized infection and sepsis).
- Tetany due to the absence of the parathyroid glands.
The three pillars of endocrinopathy treatment: EPT. E — Etiotropic (remove the cause), P — Pathogenetic (break the mechanism), T — Symptomatic (relieve symptoms).
Class and exam questions
It involves eliminating or reducing the impact of pathogenic factors on the gland. Such factors include, for example, mechanical trauma or high-dose radiation exposure.
The essence lies in eliminating, stopping, or reducing the intensity and duration of pathogenic factors acting on the gland. Physical factors requiring elimination include radiation and trauma.
Why are hormonal preparations used in endocrinology?
They are used as replacement (pathogenetic) therapy in cases of bodily deficiency of native hormones or insufficiency of their biological effects.
What is thymopentin and when is it prescribed?
Thymopentin is a drug that is a fragment of the thymopoietin hormone (amino acid residues 32–36). It is used to treat primary immunodeficiencies such as DiGeorge syndrome.
What objectives does symptomatic therapy achieve?
It is aimed at preventing and eliminating distressing symptoms that exacerbate the patient's condition. For this purpose, anti-stress agents, hypo-/hypertensive drugs, tranquilizers, and medications to normalize metabolism are used.
What else to study on this topic
- Mechanisms of T-lymphocyte differentiation under the action of thymosins in vitro.
- The effect of thymopoietins on the secretory activity of pituitary corticotrophs.
- Features of the binding of thymus hormones to cholinergic receptors.
- Pathophysiology of DiGeorge syndrome and the rationale for immunotherapy.
- Blood transport proteins and mechanisms of hormone transfer in interstitial fluid.
Master the entire topic in the "Pathophysiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Principles of Endocrinopathy Therapy" and 4,913 more pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 135 video lessons on the subject
Other topics in "Chapter 27. Typical Forms of Endocrine System Pathology"
Free video lessons: pathophysiologyShort lessons with lecture notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.